Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bushell

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Exploratory Research in Clinical and Social Pharmacy|October 21, 2022
Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact?Laura J Mackenzie, Mary-Jessimine A Bushell, Phillip Newman, et al.
Transplantation Proceedings|February 1, 1995
Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allograftsK Hamano, M Rawsthorne, A Bushell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2015
Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse DetectionS C Juvet, S Sanderson, J Hester, et al.
Transplantation|June 15, 1996
Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsivenessD Saitovitch, A Bushell, D W Mabbs, et al.
Transplantation Proceedings|March 27, 2001
Comparison of the effects of exposure to a single or multiple donor alloantigens in the development of transplant arteriosclerosisS M Ensminger, A Lieder, A Bushell, et al.
Journal of Pharmacy Practice and Research : Official Journal of the Society of Hospital Pharmacists of Australia|April 25, 2022
Pharmacists' experiences of consumer stockpiling: insights from COVID-19Eliza E Cameron, Simon A Moss, Samuel J Keitaanpaa, et al.
Transplantation|December 16, 2000
Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigenM Niimi, O Witzke, A Bushell, et al.
Transplantation|February 27, 1996
Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibodyR H Chen, A Bushell, S V Fuggle, et al.
The American Journal of Pathology|November 14, 2000
Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and nonrejecting heart allograftsB M Spriewald, M Hara, A Bushell, et al.
Analytical Chemistry|March 31, 2011
Evaluation of digital PCR for absolute DNA quantificationRebecca Sanders, Jim F Huggett, Claire A Bushell, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Exploratory Research in Clinical and Social Pharmacy|October 21, 2022
Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact?Laura J Mackenzie, Mary-Jessimine A Bushell, Phillip Newman, et al.
Transplantation Proceedings|February 1, 1995
Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allograftsK Hamano, M Rawsthorne, A Bushell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2015
Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse DetectionS C Juvet, S Sanderson, J Hester, et al.
Transplantation|June 15, 1996
Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsivenessD Saitovitch, A Bushell, D W Mabbs, et al.
Transplantation Proceedings|March 27, 2001
Comparison of the effects of exposure to a single or multiple donor alloantigens in the development of transplant arteriosclerosisS M Ensminger, A Lieder, A Bushell, et al.
Journal of Pharmacy Practice and Research : Official Journal of the Society of Hospital Pharmacists of Australia|April 25, 2022
Pharmacists' experiences of consumer stockpiling: insights from COVID-19Eliza E Cameron, Simon A Moss, Samuel J Keitaanpaa, et al.
Transplantation|December 16, 2000
Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigenM Niimi, O Witzke, A Bushell, et al.
Transplantation|February 27, 1996
Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibodyR H Chen, A Bushell, S V Fuggle, et al.
The American Journal of Pathology|November 14, 2000
Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and nonrejecting heart allograftsB M Spriewald, M Hara, A Bushell, et al.
Analytical Chemistry|March 31, 2011
Evaluation of digital PCR for absolute DNA quantificationRebecca Sanders, Jim F Huggett, Claire A Bushell, et al.
Pageof 5